Edwards Lifesciences Corp (EW)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	1,378,700	1,534,100	1,748,500	1,348,500	1,628,400
Revenue	US$ in thousands	5,439,500	6,004,800	5,382,400	5,232,500	4,386,300
Operating profit margin		25.35%	25.55%	32.49%	25.77%	37.12%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $1,378,700K ÷ $5,439,500K
= 25.35%

The operating profit margin of Edwards Lifesciences Corp has shown some fluctuations over the years based on the provided data. In December 31, 2020, the operating profit margin was 37.12%, indicating a strong profitability relative to sales. However, by December 31, 2021, there was a noticeable decrease to 25.77%, signifying a decline in the company's efficiency in generating profits from its core operations.

In the following years, there were fluctuations in the operating profit margin as well. By December 31, 2022, the margin improved to 32.49%, showing some recovery. Nevertheless, it dropped again to 25.55% by December 31, 2023, suggesting ongoing challenges in maintaining profitability levels.

As of December 31, 2024, the operating profit margin remained relatively stable at 25.35%. This indicates a consistent performance in the company's ability to generate profits from its operational activities, although the margin is lower compared to previous years.

Overall, the analysis of Edwards Lifesciences Corp's operating profit margin reflects a mixture of fluctuations and stability in profitability over the years, suggesting the company may be facing some operational challenges and varying market conditions impacting its bottom line.